NeuroCOV invites anyone involved in the field of Artificial Intelligence in medical technology to join the webinar on patent protection on the 16th of...
The new European research project NeuroCOV aims to investigate neurological and neuropsychological complications due to COVID-19. These include a compromised sense of smell and taste, impaired ability to concentrate, memory problems, stroke, and significant brain scan alterations among COVID-19 patients across all ages and independent of COVID-19 severity.
The impact of this new emerging pandemic, also called NeuroCOVID, is immense, and society and healthcare systems are at risk of unprecedented consequences. With a multidisciplinary and international consortium of 10 institutions, NeuroCOV strives to enhance the medical predicaments of developing NeuroCOVID, advance monitoring and treatment, as well as address the societal consequences of this major global problem.